Brain beta-amyloid measures and magnetic resonance imaging atrophy both predict time-to-progression from mild cognitive impairment to Alzheimer's disease

Clifford R. Jack, H. Wiste, Prashanthi Vemuri, +12

Brain

AgingNeurochemical BiomarkersLongitudinal NeuroimagingAlzheimer's DiseaseNeurology +16

MRI and CSF biomarkers in normal, MCI, and AD subjects

Prashanthi Vemuri, H. Wiste, Stephen D. Weigand, +6

Neurology

MRI and CSF biomarkers in normal, MCI, and AD subjects

Prashanthi Vemuri, H. Wiste, Stephen D. Weigand, +6

Neurology

Short-term clinical outcomes for stages of NIA-AA preclinical Alzheimer disease

David S. Knopman, Clifford R. Jack, H. Wiste, +10

Neurology

Serial MRI and CSF biomarkers in normal aging, MCI, and AD

Prashanthi Vemuri, H. Wiste, Stephen D. Weigand, +8

Neurology

Maternal and foetal outcomes in pregnant patients with active lupus nephritis

SJ Wagner, Iasmina Craici, Damon R. Reed, +10

Lupus

GynecologyActive Lupus NephritisHigh-risk PregnancyMaternal ImmunizationGlomerulonephritis +19

Cerebral venous sinus thrombosis

Izabela Gosk−Bierska, Waldemar E. Wysokiński, Robert D. Brown, +5

Neurology

A computational model of neurodegeneration in Alzheimer’s disease

David T. Jones, Val J. Lowe, Jonathan Graff‐Radford, +12

Nature Communications

Left ventricular lead position for cardiac resynchronization: a comprehensive cinegraphic, echocardiographic, clinical, and survival analysis

Yun-xu Dong, Brian D. Powell, Samuel J. Asirvatham, +9

EP Europace

Effects of Age on the Glucose Metabolic Changes in Mild Cognitive Impairment

Kejal Kantarci, Matthew L. Senjem, Val J. Lowe, +9

American Journal of Neuroradiology